Literature DB >> 18040802

Morphine withdrawal dramatically reduces lymphocytes in morphine-dependent macaques.

Michael R Weed1, Lucy M Carruth, Robert J Adams, Nancy A Ator, Robert D Hienz.   

Abstract

The immune effects of chronic opiate exposure and/or opiate withdrawal are not well understood. The results of human studies with opiate abusers are variable and may not be able to control for important factors such as subjects' drug histories, health and nutritional status. Nonhuman primate models are necessary to control these important factors. A model of opiate dependence in macaques was developed to study the effects of opiate dependence and withdrawal on measures of immune function. Four pigtailed macaques drank a mixture of morphine (20 mg/kg/session) and orange-flavored drink every 6 h for several months. During stable morphine dependence, absolute numbers of neutrophils, monocytes and lymphocytes did not change relative to pre-morphine levels. However, there was a significant decrease in the absolute number and percentage of natural killer (NK) cells in morphine dependence. Either precipitated withdrawal or abstinence for 24 h resulted in behavioral withdrawal signs in all animals. Absolute lymphocyte counts decreased and absolute netrophil counts increased significantly in withdrawal, relative to levels during morphine dependence. Lymphocyte subset (CD4+, CD8+, CD20+) cells were also decreased in absolute numbers with little change in their percentage distributions. There was, however, a significant increase in the percentage of NK cells in withdrawal relative to levels during morphine dependence. This study demonstrates the usefulness of voluntary oral self-dosing procedures for maintaining morphine dependence in nonhuman primates and demonstrates that the morphine withdrawal syndrome includes large alterations in blood parameters of immune system function, including nearly 50% reduction in numbers of CD4+, CD8+ and CD20+ cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18040802     DOI: 10.1007/s11481-006-9029-z

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  40 in total

1.  Differential tolerance to morphine's immunomodulatory effects following continuous administration.

Authors:  J P West; L A Dykstra; D T Lysle
Journal:  Drug Alcohol Depend       Date:  1998-12-01       Impact factor: 4.492

2.  Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse.

Authors:  R J Weber; R Gomez-Flores; J E Smith; T J Martin
Journal:  J Neuroimmunol       Date:  2004-02       Impact factor: 3.478

3.  Voluntary morphine ingestion, morphine dependence, and recovery from withdrawal signs.

Authors:  K A Khavari; T C Peters; P L Baity; A S Wilson
Journal:  Pharmacol Biochem Behav       Date:  1975 Nov-Dec       Impact factor: 3.533

4.  Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine.

Authors:  J P West; L A Dykstra; D T Lysle
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

Review 5.  Effects of opioids on the hypothalamo-pituitary-adrenal axis.

Authors:  R N Pechnick
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

6.  The pharmacokinetics of heroin in patients with chronic pain.

Authors:  C E Inturrisi; M B Max; K M Foley; M Schultz; S U Shin; R W Houde
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

Review 7.  Clinical pharmacokinetics of morphine.

Authors:  Ralph A Lugo; Steven E Kern
Journal:  J Pain Palliat Care Pharmacother       Date:  2002

8.  Morphine pellet-induced immunomodulation in mice: temporal relationships.

Authors:  H U Bryant; E W Bernton; J W Holaday
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

9.  Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice.

Authors:  H N Bhargava; R V House; S N Thorat; P T Thomas
Journal:  Brain Res       Date:  1995-08-28       Impact factor: 3.252

10.  The alterations of immunological reactivity in heroin addicts and their normalization in patients maintained on methadone.

Authors:  A Zajícová; H Wilczek; V Holán
Journal:  Folia Biol (Praha)       Date:  2004       Impact factor: 0.906

View more
  10 in total

1.  Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.

Authors:  Costin Tomescu; Fuh-Mei Duh; Michael A Lanier; Angela Kapalko; Karam C Mounzer; Maureen P Martin; Mary Carrington; David S Metzger; Luis J Montaner
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

2.  Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort.

Authors:  E Jennifer Edelman; Debbie M Cheng; Evgeny M Krupitsky; Carly Bridden; Emily Quinn; Alexander Y Walley; Dmitry A Lioznov; Elena Blokhina; Edwin Zvartau; Jeffrey H Samet
Journal:  AIDS Behav       Date:  2015-06

3.  Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques.

Authors:  William D Cornwell; Mark G Lewis; Xiaoxuan Fan; Jay Rappaport; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2013-09-20       Impact factor: 3.478

4.  The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.

Authors:  E J Edelman; K S Gordon; J P Tate; W C Becker; K Bryant; K Crothers; J R Gaither; C L Gibert; A J Gordon; Bdl Marshall; M C Rodriguez-Barradas; J H Samet; M Skanderson; A C Justice; D A Fiellin
Journal:  HIV Med       Date:  2016-11       Impact factor: 3.180

Review 5.  Opioid administration following spinal cord injury: implications for pain and locomotor recovery.

Authors:  Sarah A Woller; Michelle A Hook
Journal:  Exp Neurol       Date:  2013-03-15       Impact factor: 5.330

6.  THE EFFECTS OF OPIUM ADDICTION ON THYROID AND SEX HORMONES IN DIABETIC AND NON-DIABETIC MALE AND FEMALE RATS.

Authors:  G Asadikaram; H Akbari; S Vakili; M Asiabanha; N Shahrokhi; A Savardashtaki
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

7.  Persons who inject drugs (PWID) retain functional NK cells, dendritic cell stimulation, and adaptive immune recall responses despite prolonged opioid use.

Authors:  Costin Tomescu; Krystal Colon; Peter Smith; Mack Taylor; Livio Azzoni; David S Metzger; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2020-12-02       Impact factor: 6.011

8.  Impact of illicit opioid use on T cell subsets among HIV-infected adults.

Authors:  E Jennifer Edelman; Kaku So-Armah; Debbie M Cheng; Margaret F Doyle; Sharon M Coleman; Carly Bridden; Natalia Gnatienko; Dmitry A Lioznov; Elena Blokhina; Matthew S Freiberg; Evgeny M Krupitsky; Brinda Emu; Jeffrey H Samet
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

9.  A review on hematological factors in opioid-dependent people (opium and heroin) after the withdrawal period.

Authors:  Tahereh Haghpanah; Mohammadreza Afarinesh; Kouros Divsalar
Journal:  Addict Health       Date:  2010 Winter-Spring

10.  Hematological changes in opium addicted diabetic rats.

Authors:  Gholamreza Asadikaram; Majid Sirati-Sabet; Majid Asiabanha; Nader Shahrokhi; Abdollah Jafarzadeh; Mohammad Khaksari
Journal:  Int J High Risk Behav Addict       Date:  2013-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.